Inventor · disambiguated record
Robert Pullin
Also filed as: PULLIN ROBERT
8 granted patents·8 pending applications·16 citations·filing 2019–2025
82Inventor score
Top patents by PatentIndex Score
16 records- 0195US11834441B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Dec 5, 2023·4 cites·62 claims
- 0295US11827627B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Nov 28, 2023·3 cites·37 claims
- 0394US11919887B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Mar 5, 2024·2 cites·21 claims
- 0493US12247021B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 11, 2025·1 cites·24 claims
- 0585US2025197381A1Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0683US10793563B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 6, 2020·3 cites·28 claims
- 0780US12258333B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·22 claims
- 0880US10988477B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Apr 27, 2021·3 cites·20 claims
- 0980US2025059190A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 1069US2025353836A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 1162US12084438B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 10, 2024·0 cites·25 claims
- 1260US2024294512A1Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1359US2022340577A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 1458US2024400544A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1558US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1657US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Pullin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →